9802 related articles for article (PubMed ID: 1305026)
1. Possible relation between HLA and ABO type and prognosis of uveal melanoma.
Jager MJ; Völker-Dieben HJ; de Wolff-Rouendaal D; Kakebeeke-Kemme H; D'Amaro J
Doc Ophthalmol; 1992; 82(1-2):43-7. PubMed ID: 1305026
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
3. HLA antigen expression on uveal melanoma cells in vivo and in vitro.
de Waard-Siebinga I; Kool J; Jager MJ
Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229
[TBL] [Abstract][Full Text] [Related]
4. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
6. HLA expression in uveal melanoma: there is no rule without some exception.
Jager MJ; Hurks HM; Levitskaya J; Kiessling R
Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
[TBL] [Abstract][Full Text] [Related]
7. A comparison of HLA genotype with inflammation in uveal melanoma.
van Essen TH; Bronkhorst IH; Maat W; Verduyn W; Roelen DL; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2640-6. PubMed ID: 22447860
[TBL] [Abstract][Full Text] [Related]
8. Expression of HLA antigens in paraffin sections of uveal melanomas.
Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
[TBL] [Abstract][Full Text] [Related]
10. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
12. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
13. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
14. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
15. HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis.
Pollack MS; Livingston PO
Tissue Antigens; 1985 Oct; 26(4):262-5. PubMed ID: 3878014
[TBL] [Abstract][Full Text] [Related]
16. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
[TBL] [Abstract][Full Text] [Related]
17. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
[TBL] [Abstract][Full Text] [Related]
18. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
Xia F; Yu Z; Deng A; Gao G
Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of heterozygosity on chromosome 6p in uveal melanoma.
Metzelaar-Blok JA; Jager MJ; Moghaddam PH; van der Slik AR; Giphart MJ
Hum Immunol; 1999 Oct; 60(10):962-9. PubMed ID: 10566596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]